The risk factors for deep and Superficial chest surgical-site infections after coronary artery bypass graft surgery are different. J Thorac Cardiovasc Surg. 2002; 124:136 45. 657. Quist-Paulsen P, Bakke PS, Gallefoss F. Predictors of smoking ces- sation in patients admitted for acute coronary heart disease. Eur J Car- diovasc Prev Rehabil. 2005;12:472 7. 658. Rigotti NA, McKool KM, Shiffman S. Predictors of smoking cessation after coronary artery bypass graft surgery. Results of a randomized trial with 5 year follow-up. Ann Intern Med. 1994;120:287 93. 659. Harrington KF, Bailey WC. Smoking cessation through the utilization of pharmacotherapy. Expert Rev Respir Med. 2009;3:475 85. 660. Hurt RD, Sachs DP, Glover ED, et al. A comparison of sustained- release bupropion and placebo for smoking cessation. N Engl J Med. 1997;337:1195 202. 661. Jorenby DE, Hays JT, Rigotti NA, et al. efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial [published correction appears in JAMA. 2006;296: 1355]. JAMA. 2006;296:56 63. 662. Hubbard R, Lewis S, Smith C, et al. Use of nicotine replacement therapy and the risk of acute myocardial infarction, stroke, and death. Tob Control. 2005;14:416 21. 663. Lee AH, Afessa B. The association of nicotine replacement therapy with mortality in a medical intensive care unit. Crit Care Med. 2007; 35:1517 21. 664. Paciullo CA, Short MR, Steinke DT, et al. Impact of nicotine replacement therapy on postoperative mortality following coronary artery bypass graft surgery. Ann Pharmacother. 2009;43:1197 202. 665. Blumenthal JA, Lett HS, Babyak MA, et al. Depression as a risk factor for mortality after coronary artery bypass surgery. Lancet. 2003;362: 604 9. 666. Connerney I, Shapiro PA, McLaughlin JS, et al. Relation between depression after coronary artery bypass surgery and 12 month out- come: a prospective study. Lancet. 